Patents Assigned to Galephar M/F
  • Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin
    Publication number: 20150037414
    Abstract: A controlled Release Pharmaceutical composition comprising an effective amount of Pravastatin and Fenofibrate, characterised in that the difference, in absolute value, between the times of maximal concentration (Tmax) of Pravastatin and Fenofibric acid is not less than 1.5 hours upon administration with food to humans.
    Type: Application
    Filed: July 7, 2010
    Publication date: February 5, 2015
    Applicant: GALEPHAR M/F
    Inventors: Arthur M. Deboeck, Philippe Baudier, Francis Vanderbist, Antonio Sereno
  • PHARMACEUTICAL SEMI-SOLID COMPOSITION OF ISOTRETINOIN
    Publication number: 20130217769
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: December 13, 2012
    Publication date: August 22, 2013
    Applicants: GALEPHAR M/F
    Inventors: Francis Vanderbist, Cécile Servais, Phillippe Baudier
  • Pharmaceutical semi-solid composition of isotretinoin
    Patent number: 7435427
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: October 14, 2008
    Assignee: Galephar M/F
    Inventors: Francis Vanderbist, Cecile Servais, Philippe Baudier
  • Pharmaceutical semi-sold composition of isotretinoin
    Publication number: 20080171084
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e.
    Type: Application
    Filed: August 22, 2007
    Publication date: July 17, 2008
    Applicant: GALEPHAR M/F
    Inventors: Francis VANDERBIST, Cecile SERVAIS, Phillippe BAUDIER
  • Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respiratory disorders
    Publication number: 20080107740
    Abstract: Pharmaceutical composition for inhalation, containing as active ingredient effective amounts of salmeterol or a physiologically salt of salmeterol or a solvate thereof, and budesonide or a therapeutically salt of budesonide or a solvate thereof, wherein the molecular ratio of salmeterol component to budesonide component is in the range 1:2 to 1:50, together with a pharmaceutically acceptable carrier.
    Type: Application
    Filed: September 13, 2007
    Publication date: May 8, 2008
    Applicant: GALEPHAR M/F
    Inventors: Arthur Deboeck, Philippe Baudier, Francis Vanderbist
  • Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin
    Publication number: 20070092567
    Abstract: A controlled Release Pharmaceutical composition comprising an effective amount of Pravastatin and Fenofibrate, characterised in that the difference, in absolute value, between the times of maximal concentration (Tmax) of Pravastatin and Fenofibric acid is not less than 1.5 hours upon administration with food to humans.
    Type: Application
    Filed: February 6, 2006
    Publication date: April 26, 2007
    Applicant: GALEPHAR M/F
    Inventors: Arthur Deboeck, Philippe Baudier, Francis Vanderbist, Antonio Sereno
  • Advantageous combination for inhalation of nacystelyn and bronchodilators
    Publication number: 20070071689
    Abstract: pharmaceutical combination or composition for inhalation a fixed combination (A) L-lysine N-acetylcysteinate and (B) a bronchodilator agent for simultaneous, sequential or separate administration by inhalation in the treatment of an inflammatory or obstructive respiratory disease.
    Type: Application
    Filed: August 6, 2003
    Publication date: March 29, 2007
    Applicant: GALEPHAR M/F
    Inventors: Arthur Deboeck, Philippe Baudier, Francis Vanderbist